Objective:To explore the care needs of primary caregivers of children with acute lymphoblastic leukemia (ALL) developed chemotherapy-induced oral mucositis (CTOM) during hospitalization and to provide a basis for improving the caregivers′ ability to care for the children and promoting their recovery.Methods:This study adopted the phenomenological design of a qualitative approach, using purposive sampling to select 10 primary caregivers of children with ALL who developed CTOM in Zhongshan People′s Hospital from September 2022 to August 2023. A semi-structured, in-depth interview was conducted to collect the data. Colaizzi analysis was used to analyze the qualitative data.Results:Among the 10 children, 5 were males and 5 were females, aged 3-13 years old; among the 10 primary caregivers, 3 were males and 7 were females, aged 31-44 years old. The primary caregivers′ care needs were categorized into four themes: wound care needs (active oral cleaning and hygiene maintenance, lack of ability to observe wounds, and anticipation of new and more effective medications); the need for knowledge of diseases (lack of knowledge related to the causes of CTOM, lack of knowledge about care and medication, seeking information from multiple sources); nutritional knowledge and dietary care needs (active supplementation awareness, limited dietary choices, lack of specific nutritional knowledge);and social network and psychological support needs (experience sharing in primary caregiver networks, psychosocial support in primary caregiver networks).Conclusions:Primary caregivers have particular problems in caring for children with ALL developed CTOM, including the need for nursing knowledge and practical skills, social support, etc. Healthcare professionals should provide the necessary support and assistance in terms of professional resources, hospital management resources and social resources.

Objective:To explore the care needs of primary caregivers of children with acute lymphoblastic leukemia (ALL) developed chemotherapy-induced oral mucositis (CTOM) during hospitalization and to provide a basis for improving the caregivers′ ability to care for the children and promoting their recovery.Methods:This study adopted the phenomenological design of a qualitative approach, using purposive sampling to select 10 primary caregivers of children with ALL who developed CTOM in Zhongshan People′s Hospital from September 2022 to August 2023. A semi-structured, in-depth interview was conducted to collect the data. Colaizzi analysis was used to analyze the qualitative data.Results:Among the 10 children, 5 were males and 5 were females, aged 3-13 years old; among the 10 primary caregivers, 3 were males and 7 were females, aged 31-44 years old. The primary caregivers′ care needs were categorized into four themes: wound care needs (active oral cleaning and hygiene maintenance, lack of ability to observe wounds, and anticipation of new and more effective medications); the need for knowledge of diseases (lack of knowledge related to the causes of CTOM, lack of knowledge about care and medication, seeking information from multiple sources); nutritional knowledge and dietary care needs (active supplementation awareness, limited dietary choices, lack of specific nutritional knowledge);and social network and psychological support needs (experience sharing in primary caregiver networks, psychosocial support in primary caregiver networks).Conclusions:Primary caregivers have particular problems in caring for children with ALL developed CTOM, including the need for nursing knowledge and practical skills, social support, etc. Healthcare professionals should provide the necessary support and assistance in terms of professional resources, hospital management resources and social resources.

Paroxysmal sympathetic hyperactivity (PSH) is mainly secondary to a variety of acquired brain injuries, with the highest incidence of traumatic brain injury. Multiple symptoms such as paroxysmal tachycardia, shortness of breath, hypertension, hyperthermia and dystonia can occur simultaneously and repeatedly. The pathophysiological mechanism of PSH is complex. At present, drug treatment is mainly used to control symptoms; however, the combined use of multiple drugs will bring different degrees of toxic and side effects to multiple organs such as liver, kidney and lung while inhibiting sympathetic excitement. This paper mainly reviews the recent advance in non-drug treatment of PSH after craniocerebral injury from 4 aspects: nutritional support, hyperbaric oxygen therapy, avoidance of adverse stimulation and family support to standardize the PSH comprehensive management, and reduce episodes in order to improve prognosis and provide reference for clinical treatment.

Objective:To investigate the etiologies and clinical characteristics of bilateral adrenal lesions.Methods:The clinical data of 143 patients with bilateral adrenal lesions hospitalized in the First Affiliated Hospital of Chongqing Medical University from Jan. 2013 to Mar. 2018 were collected and analyzed.Results:140 patients were retained for final analysis. 79 were men, and 61 were women. The age was (51.53±13.93) years. Regarding the etiologies, there were primary aldosteronism ( n=44, 31.43%) , Cushing’s syndrome ( n=27, 19.29%) , non-functional lesions ( n=23, 16.43%) , adrenal tuberculosis ( n=17, 12.14%) , pheochromocytoma ( n=11, 7.86%) , congenital adrenal hyperplasia ( n=5, 3.57%) , adrenal metastases ( n=5, 3.57%) , and adrenal lymphoma ( n=4, 2.86) . These patients were classified into the following groups according to the mass size: ≤2 cm, 2-4 cm and ≥4 cm. The highest proportion of primary aldosteronism (62.79%) , Cushing’s syndrome (46.15%) and pheochromocytoma (31.25%) was observed in the ≤2 cm, 2-4 cm and ≥4 cm groups, respectively. The mass sizes of primary aldosteronism, Cushing’s syndrome and pheochromocytoma were compared, with pheochromocytoma the largest, followed by Cushing’s syndrome, non-functional lesion, and primary aldosteronism. Conclusions:For patients with bilateral adrenal lesions in our hospital, primary aldosteronism and Cushing’s syndrome are more common than non-functional lesion. Mass size is of great value in the diagnosis of endocrinological etiology, as well as distinguishing malignant tumors from the benign ones. The imaging phenotype is helpful to determine tumor types.

Objective:To evaluate the immunogenicity and immune persistence of purified Vero cells rabies vaccine (PVRV) with Zagreb and Essen regimen.Methods:Prospective study: Patients with first Class II exposure to rabies were recruited from the Dog Injury Cinic of Guangxi Center for Disease Control and Prevention (Guangxi CDC) and randomly divided into the Zagreb (2-1-1) and Essen (1-1-1-1-1) regimen group. All patients were inoculated with the vaccines from the same manufacturer and batch, and 3 ml serum was collected at the 45th day and in 1-year, 2-year and 3-year after immunization. Rapid fluorescent inhibition test (RFFIT) was used to detect rabies virus neutralizing antibody (RVNA). The attenuation of RVNA positive rate and geometric mean titer (GMT) with time was analyzed. Retrospective study: The informed consents for rabies vaccine in the Dog Injury Clinic of Guangxi CDC were checked out. The patients who were injected with PVRV (same manufacturer but unlimited batch) but without passive immune agents for the first time within 3 years were selected and divided into 1-year, 2-year and 3-year group. Each group was further divided into Zagreb and Essen regimen group. The serum (3 ml) was collected at 1 year, 2 years and 3 years after immunization and detected the RVNA by RFFIT.Results:Prospective study: The RVNA positive rates on the 45th day and in 1-year, 2-year and 3-year after immunizationin in the Zagreb and Essen regimen group were 100%, 95%, 85%, 80% and 98.25%, 89.47%, 89.47%, 85.96%, respectively. There was no statistically significant difference in the RVNA positive rates at the same time point between the two regimen groups ( P>0.05). The RVNA GMT on the 45th day and in 1-year, 2-year, and 3-year in the Zagreb and Essen regimen group were 11.32 IU/ml, 1.69 IU/ml, 1.30 IU/ml, 1.30 IU/m and 13.18 IU/ml, 2.13 IU/ml, 1.87 IU/ml, 1.84 IU/m, respectively. There was no significant difference in the RVNA GMT levels at the same time point between the two regimen groups ( F=1.971, P=0.164). The RVNA GMT levels in the two regimen groups had the same trend of attenuation over time (time*group F=0.702, P=0.435). Retrospective study: The RVNA positive rates in 1-year, 2-year and 3-year after immunization in the Zagreb and Essen regimen group were 100%, 95%, 91.43%和94.73%, 86.21%, 87.5%, respectively. There was no statistically significant difference in the RVNA positive rates at the same time point between the two regimen groups ( P>0.05). The RVNA GMT in 1-year, 2-year, and 3-year groups after immunization in the Zagreb and Essen regimen group were 2.65 IU/ml, 2.03 IU/ml, 1.57 IU/ml和3.2 IU/ml, 2.58 IU/ml, 2.45 IU/ml, respectively. There was no significant difference in the RVNA GMT levels at the same time point between the two regimen groups ( P>0.05). Conclusions:The PVRV showed the same excellent immunogenicity and immune persistence after the vaccination with the Zagreb and Essen regimens.